Social Anxiety Disorder

Social Anxiety Disorder (SAD) is a chronic psychiatric condition characterized by intense, persistent fear of social or performance situations in which an individual is exposed to potential scrutiny by others. Patients experience overwhelming apprehension regarding negative evaluation, leading to significant functional impairment and avoidance behavior.

SAD arises from a complex interplay of genetic, environmental, and psychological factors. Genetic predisposition accounts for approximately 30-40% of the variance. Environmental factors include early childhood experiences such as social inhibition, overprotective parenting, or traumatic social bullying. Lifestyle factors, such as high-stress environments or prolonged social isolation, can exacerbate latent tendencies.

Pathophysiology involves the amygdala, which shows hyper-responsivity to social stimuli. Functional imaging reveals increased connectivity between the amygdala and the anterior cingulate cortex. Neurochemical imbalances involve serotonin, dopamine, and GABAergic dysregulation, leading to a heightened "fight-or-flight" response in benign social scenarios.

SAD is among the most prevalent anxiety disorders. Lifetime prevalence is estimated at 7-12% in the general population. It typically presents in adolescence or early adulthood. There is a slight female predominance, though this may reflect differences in healthcare-seeking behavior.

• Family history of anxiety disorders.
• Childhood social inhibition or shyness.
• History of childhood trauma or neglect.
• Adverse life events (e.g., public humiliation).
• Impaired social skill development.

A. Early Symptoms

• Persistent fear of meeting new people.


• Excessive worry about upcoming social events.


• Avoiding eye contact in casual interactions. B. Common Symptoms


• Excessive self-consciousness.


• Blushing, sweating, or trembling in groups.


• Fear of judgment or embarrassment.


• Avoidance of speaking in public. C. Advanced Symptoms


• Isolation from peers or coworkers.


• Substance abuse (as a coping mechanism).


• Panic attacks in social settings.


• Agoraphobic tendencies. D. Emergency Symptoms


• Suicidal ideation.


• Severe depressive episodes.


• Substance-induced psychosis.

Physical findings are often unremarkable; however, clinicians may observe autonomic arousal signs: tachycardia, tachypnea, diaphoresis, or tremors during stressful clinical interviews.

A. Clinical Assessment: Based on DSM-5/ICD-11 criteria; Structured Clinical Interview for DSM (SCID).
B. Laboratory Testing: Rule out endocrine/metabolic causes (e.g., hyperthyroidism).
C. Imaging Studies: Generally not required; used only to rule out neurological conditions.
D. Functional Tests: Not applicable.
E. Biopsy Findings: N/A.
F. Genetic Testing: Not indicated.
G. Differential Diagnosis: Panic disorder, Agoraphobia, Autism Spectrum Disorder.

Thyroid Stimulating Hormone (TSH)
Type: Blood Test
Purpose: Exclude hyperthyroidism causing anxiety symptoms.
Expected Findings: Normal range.
Interpretation: Abnormalities indicate organic mimics of anxiety.

MRI Brain: Reserved for atypical presentations to rule out structural neurological pathology.

• Panic Disorder: Anxiety not limited to social situations.
• Autism Spectrum Disorder: Social deficits related to communication/neurodevelopment rather than fear of evaluation.
• Body Dysmorphic Disorder: Preoccupation with appearance rather than performance.

• Major Depressive Disorder.
• Substance Use Disorder.
• Career/Educational failure.
• Social isolation.

A. Lifestyle Modifications: Mindfulness, exercise, sleep hygiene.
B. Preventive Measures: Early social exposure programs.
C. Medical Treatment: SSRIs (e.g., Sertraline), SNRIs (e.g., Venlafaxine), Beta-blockers for performance anxiety.
D. Surgical Treatment: N/A.
E. Interventional Procedures: Cognitive Behavioral Therapy (CBT).
F. Rehabilitation: Social skills training.
G. Emergency Management: Crisis intervention for suicidal ideation.

Prognosis is generally favorable with CBT and/or pharmacotherapy. Chronic cases may persist if untreated, often leading to secondary depression.

Early identification in school-aged children and social-emotional learning programs are primary preventive strategies.

The following homeopathic remedies have been historically indicated for symptoms associated with Social Anxiety Disorder. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Panic Attack & Somatic Anxiety Estimator

Evaluates somatic anxiety and panic severity using physiological symptoms (palpitations, sweating, dyspnea, tremors) and cognitive distress indicators.